PET scan study to optimize imaging in several diseases
Treatments studied
Part of Brain & nervous system, Cancer, Digestive system, Genetic & congenital, Hormones & metabolism, Mental health clinical trials.
This trial improves a special PET scan (a type of brain/body imaging) using 18F-DOPA, to better show how certain conditions behave in the body. If you or your child may have one of the listed conditions, the study may help your doctors get clearer scan results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are younger than 18 with congenital hyperinsulinism or neuroblastoma, or you are 18+ with one of the listed tumor or brain conditions
- The diagnosis is one of these: neuroendocrine tumor (known or suspected), Parkinson’s disease, Lewy body dementia, or a brain tumor
- You can give consent (or a parent/guardian can) for the scan study
- You can stay in the scanner and lie flat for about 20–30 minutes during the PET-CT
- You have no pregnancy and can safely receive an IV medicine (you have IV access)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
This Phase 2 study uses an FDOPA PET scan to find where insulin overproduction is coming from in focal congenital hyperinsulinism (FoHI) or related conditions. The goal is to help doctors better detect and localize the “source” so treatment can be more targeted.
This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.
This study uses a special PET scan to look at inflammation in the brain of people with Parkinson's disease or those at risk for it. The goal is to better understand the disease and possibly find new ways to track its progression.
This trial compares two different nuclear medicine scans to see which one best shows where neuroblastoma is in a child’s body. The results may help doctors choose the most helpful scan for planning care.
This study tests a new way to take brain imaging scans (PET scans) using a very small amount of radioactive tracer. Researchers want to see if they can get clear pictures of your brain while reducing your radiation exposure compared to standard scans.
Hear when a new Congenital Hyperinsulinism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.